CRANBURY, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. today announced that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Palace Hotel in New York on Monday, November 5, 2007 at 4:45 PM ET.
Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on the Company’s corporate and development programs. To access the live audio broadcast or the subsequent archived recording, log onto www.palatin.com.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company’s internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies’ website at http://www.palatin.com.
CONTACT: Stephen T. Wills, CPA, MST, EVP-Operations - Chief Financial
Officer of Palatin Technologies, +1-609-495-2200, info@palatin.com; or
Investors and Media, Carney Noensie of Burns McClellan, +1-212-213-0006,
cnoensie@burnsmc.com, for Palatin Technologies
Web site: http://www.palatin.com/
